瘤生物学隐藏了新的治疗方法来扩散大B细胞淋巴瘤:叙述性审查
相关实验视频
Updated: Jun 7, 2025

10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
9.8K
Romana Masnikosa1, Zorica Cvetković2,3, David Pirić1
1Department of Physical Chemistry, Vinca Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, Mike Petrovica Alasa 12-14, 11000 Belgrade, Serbia.
International journal of molecular sciences
|November 9, 2024
概括
扩散性大B细胞淋巴瘤 (DLBCL) 研究突出了新药点在新陈代谢,脂质通路和肠道微生物群中. 探索这些领域可能会提高治疗效率和超越当前治疗方法的患者结果.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 具有显著的生物学和临床异质性.
- 基于转录组学/基因组学的现有分类方案使得一些DLBCL样本未被分类.
- 目前的治疗策略面临的挑战是药物耐药性和毒性.
研究的目的:
- 审查DLBCL瘤生物学,并确定实际和潜在的药物点.
- 讨论DLBCL目前和新兴的治疗方式.
- 探索新的治疗途径,包括代谢途径,脂质途径,铁和肠道微生物群.
主要方法:
- 对DLBCL瘤生物学进行文献综述和分析.
- 讨论各种治疗方式 (小分子抑制剂,抗体,CAR-T等). ) 的情况.
- 对DLBCL文献 (2014-2023) 的图书统计和知识图分析.
主要成果:
- 表观遗传改变,B细胞受体和NF-κB通路是有希望的目标.
- 脂质通路,铁亡和肠道微生物组代表了新的可药物向目标.
- 目前正在进行的临床试验显示出有希望的结果,但与毒性和折射性有关.
结论:
- 在DLBCL新陈代谢,脂质通路和肠道微生物群中的新目标可以增强免疫化疗.
- 对DLBCL代谢的进一步研究对于发现新的治疗点至关重要.
- 改善患者健康状况和治愈率需要探索这些新兴策略.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

